Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NEXUS AG ( (DE:NXU) ) just unveiled an announcement.
NEXUS AG announced that no shares were bought back between May 5 and May 9, 2025, as part of its ongoing share buy-back program, which started in July 2023. The total volume of shares repurchased under this program is 63,432, with transactions conducted exclusively on the Frankfurt Stock Exchange’s electronic trading platform, Xetra. This buy-back initiative reflects the company’s strategic approach to managing its capital structure and potentially enhancing shareholder value.
The most recent analyst rating on (DE:NXU) stock is a Hold with a EUR70.0000 price target. To see the full list of analyst forecasts on NEXUS AG stock, see the DE:NXU Stock Forecast page.
More about NEXUS AG
NEXUS AG operates in the healthcare industry, focusing on providing software solutions for hospitals and healthcare facilities. The company is known for its comprehensive range of products that enhance medical and administrative processes, aiming to improve the efficiency and quality of healthcare services.
YTD Price Performance: 2.17%
Average Trading Volume: 1,086
Technical Sentiment Signal: Buy
Current Market Cap: €1.22B
See more insights into NXU stock on TipRanks’ Stock Analysis page.